OVKATE
1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
OVKATE is a human ovarian carcinoma cell line derived from a serous papillary adenocarcinoma solid tumor. These cells express various cytokeratins (CKs 6, 7, 8, 13, 17, 18, 19, 20, 15, and/or 16) and are negative for CKs 10 and 14. Additionally, OVKATE cells are positive for vimentin, EMA, and EGF receptors, while negative for desmin, S-100, myoglobin, type II collagen, α-smooth muscle actin, and glial fibrillary acidic protein. They exhibit transplantability to both mouse hypodermis and abdominal regions, forming tumors with sheet-like structures, solid nests, or papillary structures composed of oval- to spindle-shaped cells.
Why choose OVKATE from AcceGen?
The OVKATE cell line from AcceGen is characterized by high viability and exceptional quality. It is provided in a sterile condition, ensuring it is free from contaminants such as bacteria, fungi, and mycoplasma. Furthermore, real-time PCR has confirmed its negative status for human pathogens, making it a reliable and safe resource for research applications.
| Species | Human |
| Cat.No | ABC-TC0882 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Ovary |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Ovarian Cancer Cell Lines |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
FOR RESEARCH USE ONLY
The OVKATE cell line serves as a vital resource in the field of human ovarian carcinoma research. It is employed for genomics studies and the creation of xenograft models, enabling in-depth investigations into the molecular mechanisms underlying this cancer type. Furthermore, OVKATE cells offer a valuable experimental system for the study of regulatory control mechanisms related to intermediate filament expression. Additionally, they are instrumental in testing the anti-proliferative effects of potential drugs, facilitating the evaluation of novel therapeutic approaches in the context of ovarian carcinoma.
OVKATE cells were originally isolated from ovary of a stage IIIc ovarian tumor patient.
The OVKATE cell line grow slowly. The doubling time would be over 1 week.
Yes. Cells are form tumors by SC injection.
